These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 15810885

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dendritic cells undergo rapid apoptosis in vitro during antigen-specific interaction with CD4+ T cells.
    Matsue H, Edelbaum D, Hartmann AC, Morita A, Bergstresser PR, Yagita H, Okumura K, Takashima A.
    J Immunol; 1999 May 01; 162(9):5287-98. PubMed ID: 10228004
    [Abstract] [Full Text] [Related]

  • 3. Killing of naive T cells by CD95L-transfected dendritic cells (DC): in vivo study using killer DC-DC hybrids and CD4(+) T cells from DO11.10 mice.
    Kusuhara M, Matsue K, Edelbaum D, Loftus J, Takashima A, Matsue H.
    Eur J Immunol; 2002 Apr 01; 32(4):1035-43. PubMed ID: 11920570
    [Abstract] [Full Text] [Related]

  • 4. Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells.
    Roelen DL, Schuurhuis DH, van den Boogaardt DE, Koekkoek K, van Miert PP, van Schip JJ, Laban S, Rea D, Melief CJ, Offringa R, Ossendorp F, Claas FH.
    Transplantation; 2003 Dec 15; 76(11):1608-15. PubMed ID: 14702533
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Induction of antigen-specific immunosuppression by CD95L cDNA-transfected 'killer' dendritic cells.
    Matsue H, Matsue K, Walters M, Okumura K, Yagita H, Takashima A.
    Nat Med; 1999 Aug 15; 5(8):930-7. PubMed ID: 10426318
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Killer artificial antigen-presenting cells deplete alloantigen-specific T cells in a murine model of alloskin transplantation.
    Shen C, He Y, Cheng K, Zhang D, Miao S, Zhang A, Meng F, Miao F, Zhang J.
    Immunol Lett; 2011 Aug 30; 138(2):144-55. PubMed ID: 21513739
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immunosuppressive properties of CD95L-transduced "killer" hybrids created by fusing donor- and recipient-derived dendritic cells.
    Matsue H, Matsue K, Kusuhara M, Kumamoto T, Okumura K, Yagita H, Takashima A.
    Blood; 2001 Dec 01; 98(12):3465-72. PubMed ID: 11719389
    [Abstract] [Full Text] [Related]

  • 11. Prevention of allograft rejection by in vitro generated tolerogenic dendritic cells.
    Ichim TE, Zhong R, Min WP.
    Transpl Immunol; 2003 Dec 01; 11(3-4):295-306. PubMed ID: 12967783
    [Abstract] [Full Text] [Related]

  • 12. Switching from a restricted to an effective CD4 T cell response by activating CD8+ murine dendritic cells with a Toll-like receptor 9 ligand.
    Rizzitelli A, Vremec D, Villadangos JA, Mavaddat N, Wright MD, Shortman K.
    Eur J Immunol; 2005 Nov 01; 35(11):3209-20. PubMed ID: 16224811
    [Abstract] [Full Text] [Related]

  • 13. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
    Ito A, Shimura H, Nitahara A, Tomiyama K, Ito M, Kanekura T, Okumura K, Yagita H, Kawai K.
    Int Immunol; 2008 Oct 01; 20(10):1343-9. PubMed ID: 18697765
    [Abstract] [Full Text] [Related]

  • 14. Infusion of stably immature monocyte-derived dendritic cells plus CTLA4Ig modulates alloimmune reactivity in rhesus macaques.
    Zahorchak AF, Kean LS, Tokita D, Turnquist HR, Abe M, Finke J, Hamby K, Rigby MR, Larsen CP, Thomson AW.
    Transplantation; 2007 Jul 27; 84(2):196-206. PubMed ID: 17667811
    [Abstract] [Full Text] [Related]

  • 15. Differential regulation of dendritic cell-T cell cross talk in the gut-associated lymphoid tissue.
    Nicoletti C, Temblay JN, Regoli M, Bertelli E, Man AL.
    Mol Immunol; 2006 Feb 27; 43(6):542-9. PubMed ID: 15955563
    [Abstract] [Full Text] [Related]

  • 16. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H.
    Int J Oncol; 2006 Apr 27; 28(4):947-53. PubMed ID: 16525645
    [Abstract] [Full Text] [Related]

  • 17. CD1-dependent natural killer (NK1.1(+)) T cells are required for oral and portal venous tolerance induction.
    Margenthaler JA, Landeros K, Kataoka M, Flye MW.
    J Surg Res; 2002 May 01; 104(1):29-35. PubMed ID: 11971674
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Spontaneous in vivo retrovirus-infected T and B cells, but not dendritic cells, mediate antigen-specific Fas ligand/Fas-dependent apoptosis of anti-retroviral CTL.
    Rich RF, Cook WJ, Green WR.
    Virology; 2006 Mar 15; 346(2):287-300. PubMed ID: 16337984
    [Abstract] [Full Text] [Related]

  • 20. Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection.
    Zhang X, Li M, Lian D, Zheng X, Zhang ZX, Ichim TE, Xia X, Huang X, Vladau C, Suzuki M, Garcia B, Jevnikar AM, Min WP.
    Clin Immunol; 2008 Jun 15; 127(3):313-21. PubMed ID: 18358783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.